Vistin Pharma ASA ( ($DE:VP4) ) has shared an announcement. Vistin Pharma ASA announced it will release its third quarter and ...

Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on Friday 31st of October 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the ...

In 2024, around 26.4 million treatments of metformin hydrochloride were dispensed. The drug is available on prescription in ...

The NHS has a word of warning on its website for anyone who is taking metformin, though it is especially aimed at people who ...

Metformin is a generic prescription medication used to help manage blood sugar levels in adults and some children with type 2 diabetes. It works by decreasing sugar production in the liver, reducing ...

The Drugs Controller General of India (DCGI) has informed the drug controllers of states and Union Territories that the antidiabetic fixed dose combination (FDC) of voglibose 0.2 mg and metformin Hcl ...

Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk.

For decades, scientists have puzzled over how metformin, the world’s most prescribed diabetes drug, works beyond lowering blood sugar. Now, a study from Kobe University reports that metformin users ...

Metformin vs. Ozempic: What’s the Difference? Metformin (Fortamet, Glumetza) and semaglutide (Ozempic, Rybelsus) are medicines that treat type 2 diabetes. They both lower blood sugar, but they work ...